首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Betaine-Homocysteine S-Methyltransferase-2 Is an S-Methylmethionine-Homocysteine Methyltransferase
【2h】

Betaine-Homocysteine S-Methyltransferase-2 Is an S-Methylmethionine-Homocysteine Methyltransferase

机译:甜菜碱-同型半胱氨酸S-甲基转移酶-2是 S-甲基蛋氨酸-高半胱氨酸 甲基转移酶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We demonstrate that purified recombinant human betainehomocysteine methyltransferase-2 (BHMT-2) is a zinc metalloenzyme that uses S-methylmethionine (SMM) as a methyl donor for the methylation of homocysteine. Unlike the highly homologous betaine-homocysteine methyltransferase (BHMT), BHMT-2 cannot use betaine. The Km of BHMT-2 for SMM was determined to be 0.94 mm, and it has a turnover number similar to BHMT. Several compounds were tested as inhibitors of recombinant human BHMT and BHMT-2. The SMM-specific methyltransferase activity of BHMT-2 is not inhibited by dimethylglycine and betaine, whereas the former is a potent inhibitor of BHMT. Methionine is a stronger inhibitor of BHMT-2 than BHMT, and S-adenosylmethionine does not inhibit BHMT but is a weak inhibitor of BHMT-2. BHMT can use SMM as a methyl donor with a kcat/Km that is 5-fold lower than the kcat/Km for betaine. However, SMM does not inhibit BHMT activity when it is presented to the enzyme at concentrations that are 10-fold greater than the subsaturating amounts of betaine used in the assay. Based on these data, it is our current hypothesis that in vivo most if not all of the SMM-dependent methylation of homocysteine occurs via BHMT-2.
机译:我们证明,纯化的重组人甜菜碱半胱氨酸甲基转移酶2(BHMT-2)是锌金属酶,它使用S-甲基甲硫氨酸(SMM)作为高半胱氨酸甲基化的甲基供体。与高度同源的甜菜碱-高半胱氨酸甲基转移酶(BHMT)不同,BHMT-2不能使用甜菜碱。用于SMM的BHMT-2的Km确定为0.94 mm,其周转数类似于BHMT。测试了几种化合物作为重组人BHMT和BHMT-2的抑制剂。 BHMT-2的SMM特异性甲基转移酶活性不受二甲基甘氨酸和甜菜碱的抑制,而前者是BHMT的有效抑制剂。蛋氨酸是BHMT-2的强抑制剂,而不是BHMT,S-腺苷甲硫氨酸不抑制BHMT,但是BHMT-2的弱抑制剂。 BHMT可以将SMM用作甲基供体,其kcat / Km比甜菜碱的kcat / Km低5倍。但是,当SMM在酶中的BHMT活性比其在食品中所用甜菜碱的亚饱和量大10倍时,不会抑制BHMT活性。 分析。基于这些数据,我们目前的假设是体内 大多数(如果不是全部)高半胱氨酸的SMM依赖性甲基化通过 BHMT-2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号